A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...
主要な著者: | Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
American Society for Clinical investigation
2021-08-01
|
シリーズ: | JCI Insight |
主題: | |
オンライン・アクセス: | https://doi.org/10.1172/jci.insight.149217 |
類似資料
-
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
著者:: Ingrid G Rekeland, 等
出版事項: (2022-01-01) -
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
著者:: Ingrid G. Rekeland, 等
出版事項: (2022-01-01) -
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
著者:: Ingrid G Rekeland, 等
出版事項: (2024-01-01) -
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
著者:: Kari Sørland, 等
出版事項: (2021-03-01) -
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
著者:: Øystein Fluge, 等
出版事項: (2015-01-01)